New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0567
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Flightless I Homolog Represses Prostate Cancer Progression Through Targeting Androgen Receptor Signaling

Clinical Cancer Research
Cancer ResearchOncology
2015English

Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2010English

Looking Beyond Androgen Receptor Signaling in the Treatment of Advanced Prostate Cancer

Advances in Andrology
2014English

Evolution of the Androgen Receptor Pathway During Progression of Prostate Cancer

Cancer Research
Cancer ResearchOncology
2006English

New Strategy for Prostate Cancer Prevention Based on Selenium Suppression of Androgen Receptor Signaling

2007English

New Strategy for Prostate Cancer Prevention Based on Selenium Suppression of Androgen Receptor Signaling

2006English

Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Targeting Androgen Receptor and JunD Interaction for Prevention of Prostate Cancer Progression

Prostate
OncologyUrology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy